A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors
NCT07387874
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Recurrent or Metastatic Solid Tumors
Interventions
DRUG:
Trastuzumab Rezetecan
DRUG:
Other Drugs
Sponsor
Lixiaoling